PTAB Should've Axed Cancer Detection Patent, Fed. Circ. Told
Canfield Scientific Inc. has told the Federal Circuit that the Patent Trial and Appeal Board disregarded an abundance of reasons the biotech company put forth to prove that a Melanoscan LLC...To view the full article, register now.
Already a subscriber? Click here to view full article